RxDoctor Payments DataLook up a doctor →

Vahan Kassabian, MD

Urology · Roswell, GANPI 1730283284

Payments from drug & device makers

$3,042,445in general payments, 2019–2025

Across 1,947 payments — averaging $1562.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Merck$1.5M
  • Johnson & Johnson$351K
  • Astellas Pharma US Inc$248K
  • Dendreon Pharmaceuticals LLC$217K
  • Bayer$168K
  • Urogen Pharma, Inc.$110K
  • plus $425K from 54 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Merck247$1,522,066
Johnson & Johnson(3 entities)377$350,996
Astellas Pharma US Inc218$248,036
Dendreon Pharmaceuticals LLC134$217,386
Bayer158$168,087
Urogen Pharma, Inc.132$110,398
Sumitomo Pharma America, Inc.76$98,229
AstraZeneca89$85,685
Pfizer56$44,496
SN Holdings, LLC70$42,530
Myovant Sciences Inc.47$38,532
Progenics Pharmaceuticals, Inc.38$37,475
Tolmar Pharmaceuticals, Inc.15$16,556
Ferring Pharmaceuticals Inc.23$11,887
Urogpo LLC35$11,476
Immunitybio, Inc.6$9,076
Janssen Scientific Affairs, LLC8$7,698
Clovis Oncology, Inc.11$6,113
E.r. Squibb & Sons, L.L.C.3$2,359
Telix Pharmaceuticals3$1,880
Medtronic(2 entities)13$1,533
EDAP Technomed Inc6$951
Endo Pharmaceuticals Inc.19$824
Novartis8$780
Angiodynamics, Inc.10$730
Teleflex LLC7$706
Blue Earth Diagnostics17$631
Profound Medical Corp.4$584
Boston Scientific15$571
Tempus AI, Inc12$462
Lexington Medical, Inc.1$382
Baxter Healthcare4$370
Accord Healthcare, Inc.4$365
Coloplast5$241
Procept Biorobotics Corporation5$228
Neotract Inc.2$178
Ambu Inc.1$169
Astellas Pharma Inc1$141
Endo USA, Inc.5$138
Myriad Genetic Laboratories, Inc.6$136
Metuchen Pharmaceuticals1$121
C. R. Bard, Inc. & Subsidiaries3$121
Antares Pharma, Inc.6$105
Verity Pharmaceuticals Inc.6$99
Sun Pharmaceutical Industries Inc.3$98
Canon Medical Systems USA, Inc.1$82
Laborie Medical Technologies Corp.3$79
Tolmar, Inc.3$75
AbbVie(2 entities)3$60
Convatec Inc.1$48
Roche Diagnostics Corporation1$46
Urovant Sciences Inc2$40
Olympus America Inc.2$29
Vertex1$29
Astellas Pharma Global Development2$28
180 Medical, Inc.1$27
Innovation Technologies Inc1$26
Pacira Pharmaceuticals Incorporated1$26
Rochester Medical Corporation1$24
Palette Life Sciences, Inc.1$23

How this compares

$3,042,445 in reported general payments places this provider in the 95th percentile of 369 urology providers in Georgia.

See all urology providers in Georgia →

Medicare billing

Part B allowed, 2024
$520,100
Medicare patients
536
Services billed
4,236

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other urology in Roswell

See the full list for Georgia →

Where these figures come from

Is this you, or does something look wrong? →